MedTrace Logo

Baclocur® Post-Authorisation Safety Study in Real-life Settings in France

NCT04679142 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 975

Last updated 2021-01-05

No results posted yet for this study

Summary

The overall goal of the study is to further characterize the risks and the safety profile of Baclocur® in real life settings, over a 12-month follow-up period.

Conditions

Interventions

DRUG

Baclofen Tablets

Enrolled patients will receive treatment and evaluations for their disease as determined by their physicians in accordance with local standard of care. Visits will be scheduled by their physician according to patient-specific needs and national clinical practice.

Sponsors & Collaborators

  • Ethypharm

    lead INDUSTRY

Principal Investigators

  • Henri-Jean Aubin, MD, Ph.D · Hospital Paul Brousse Villejuif France

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-22
Primary Completion
2024-11-30
Completion
2025-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04679142 on ClinicalTrials.gov